Clinical Trial Update: Comparison of Aliskiren vs Negative Controls on Aortic Stiffness in Patients With MFS [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing aliskiren to negative controls to assess its effect on aortic stiffness in patients with Marfan syndrome; the trial has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marfan Syndrome

Drugs mentioned

• Tekturna (aliskiren)

Snippet

Sponsor: Samsung Medical Center | Conditions: Marfan Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2017-05-04